The tweet was deleted by the author.
But we saved everything 🙂.
Acumen Pharmaceuticals, Inc. is strengthening its commitment to developing targeted treatments for Alzheimer patients and their families.
The company reiterated the importance of supporting individuals affected by Alzheimer disease as Alzheimer and Brain Awareness Month comes to a close. Acumen Pharmaceuticals, Inc. stated that its ongoing research efforts are driven by the goal of preserving more meaningful life moments for patients, caregivers, and loved ones who are confronting the challenges of Alzheimer.
Earlier in the month, Acumen Pharmaceuticals advanced brain health research and called for increased public engagement during Alzheimer and Brain Awareness Month, according to a prior update. The company also recently nominated two Enhanced Brain Delivery candidates for Alzheimer research in partnership with JCR Pharmaceuticals, detailed in a previous release. Both initiatives align with Acumen's stated focus on supporting patients and caregivers.